Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV Pneumonia”

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04353180
What this trial is testing

Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)

Who this might be right for
COVID19
Kafrelsheikh University 100,000
Testing effectiveness (Phase 2)Study completedNCT07134725
What this trial is testing

Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG

Who this might be right for
COVID - 19
Federal University of Minas Gerais 432
Not applicableEnded earlyNCT06703190
What this trial is testing

Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine

Who this might be right for
COVID-19
Pfizer 1
Early research (Phase 1)Study completedNCT04646044
What this trial is testing

A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19

Who this might be right for
Covid-19Coronavirus Disease 2019
Nektar Therapeutics 30
Large-scale testing (Phase 3)UnknownNCT05091411
What this trial is testing

Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 1,680
Large-scale testing (Phase 3)Study completedNCT04380519
What this trial is testing

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

Who this might be right for
COVID-19
R-Pharm International, LLC 372
Not applicableWithdrawnNCT04251767
What this trial is testing

Washed Microbiota Transplantation for Patients With 2019-nCoV Infection

Who this might be right for
COVID-19 Complicated With Refractory Intestinal Infections
The Second Hospital of Nanjing Medical University
Not applicableStudy completedNCT05104411
What this trial is testing

Rehabilitation in Severely Ill Inpatients With COVID-19

Who this might be right for
COVID-19
Seoul National University Bundang Hospital 37
Not applicableEnded earlyNCT04569851
What this trial is testing

Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)

Who this might be right for
COVID-19 Infection
Savana Research 100,000
Early research (Phase 1)Study completedNCT05525910
What this trial is testing

Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants

Who this might be right for
Biological AvailabilityHealthy Participants
Pfizer 15
Early research (Phase 1)Study completedNCT04644120
What this trial is testing

Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
CoronaVirus Disease-2019 (COVID-19)
AbbVie 25
Post-approval studies (Phase 4)Study completedNCT04394117
What this trial is testing

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

Who this might be right for
Coronavirus Disease 2019COVID-19
The George Institute 787
Not applicableStudy completedNCT04389944
What this trial is testing

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Who this might be right for
Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)
University Hospital, Basel, Switzerland 15
Large-scale testing (Phase 3)UnknownNCT05187793
What this trial is testing

Study of Efficacy of Different Treatment Regimens of Olokizumab

Who this might be right for
COVID-19
R-Pharm 198
Testing effectiveness (Phase 2)Study completedNCT04547127
What this trial is testing

Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
Instituto Grifols, S.A. 200
Not applicableStudy completedNCT06735300
What this trial is testing

Saliva PCR in Pregnant Women with COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19) Pneumonia
National Cheng-Kung University Hospital 37
Early research (Phase 1)Study completedNCT05339334
What this trial is testing

Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.

Who this might be right for
Healthy Participants
Pfizer 14
Testing effectiveness (Phase 2)Ended earlyNCT04899232
What this trial is testing

Antithrombin III in Infectious Disease Caused by COVID-19

Who this might be right for
Antithrombin III DeficiencyCovid19
Enrique Ginzburg 52
Not applicableUnknownNCT04594460
What this trial is testing

Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19Hydrogen-oxygen GasAMS-H-03
Guangzhou Institute of Respiratory Disease 198
Not applicableWithdrawnNCT06163677
What this trial is testing

Look at the Health Outcomes of Patients With COVID-19 and Influenza.

Who this might be right for
COVID-19Coronavirus Disease 2019Influenza
Pfizer
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation